Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001520642-11-000001
Filing Date
2011-05-17
Accepted
2011-05-17 14:53:51
Documents
1
Effectiveness Date
2011-05-17
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9306
  Complete submission text file 0001520642-11-000001.txt   10379
Mailing Address 6724 PERIMETER LOOP ROAD SUITE 273 DUBLIN OH 43017
Business Address 6724 PERIMETER LOOP ROAD SUITE 273 DUBLIN OH 43017 614-783-2497
Silvergate Pharmaceuticals, Inc. (Filer) CIK: 0001520642 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-159955 | Film No.: 11851127